home / stock / cnbx / cnbx quote
Last: | $0.0058 |
---|---|
Change Percent: | 3.43% |
Open: | $0.00676 |
Close: | $0.0058 |
High: | $0.007 |
Low: | $0.0058 |
Volume: | 27,132 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0058 | $0.00676 | $0.0058 | $0.007 | $0.0058 | 27,132 | 07-19-2024 |
$0.007 | $0.00664 | $0.007 | $0.007 | $0.00664 | 4,405 | 07-18-2024 |
$0.0075 | $0.0075 | $0.0075 | $0.0075 | $0.0065 | 29,763 | 07-17-2024 |
$0.0075 | $0.0064 | $0.0075 | $0.0078 | $0.0064 | 96,235 | 07-16-2024 |
$0.0064 | $0.0068 | $0.0064 | $0.0078 | $0.0057 | 52,299 | 07-15-2024 |
$0.0071 | $0.0072 | $0.0071 | $0.00738 | $0.0057 | 134,393 | 07-12-2024 |
$0.0074 | $0.0074 | $0.0074 | $0.0074 | $0.0074 | 1,028 | 07-11-2024 |
$0.0071 | $0.00635 | $0.0071 | $0.0071 | $0.00635 | 62,980 | 07-10-2024 |
$0.0069 | $0.0075 | $0.0069 | $0.0075 | $0.0069 | 77,124 | 07-09-2024 |
$0.0069 | $0.0075 | $0.0069 | $0.0075 | $0.0069 | 23,467 | 07-08-2024 |
$0.0069 | $0.0075 | $0.0069 | $0.0075 | $0.0069 | 8,170 | 07-05-2024 |
$0.0071 | $0.0069 | $0.00714 | $0.0075 | $0.0069 | 16,004 | 07-04-2024 |
$0.00714 | $0.0069 | $0.00714 | $0.0075 | $0.0069 | 16,004 | 07-03-2024 |
$0.0075 | $0.0076 | $0.0075 | $0.0076 | $0.006805 | 59,230 | 07-02-2024 |
$0.0076 | $0.006935 | $0.0076 | $0.0076 | $0.00646 | 21,377 | 07-01-2024 |
$0.0057 | $0.0078 | $0.0057 | $0.0079 | $0.0057 | 43,902 | 06-28-2024 |
$0.007 | $0.0078 | $0.007 | $0.0078 | $0.006305 | 73,100 | 06-27-2024 |
$0.0076 | $0.0079 | $0.0076 | $0.0079 | $0.0051 | 251,910 | 06-26-2024 |
$0.0079 | $0.0065 | $0.0079 | $0.008 | $0.005 | 468,006 | 06-25-2024 |
$0.008 | $0.00775 | $0.008 | $0.009 | $0.00775 | 1,905 | 06-24-2024 |
News, Short Squeeze, Breakout and More Instantly...
Cannabics Pharmaceuticals Inc Company Name:
CNBX Stock Symbol:
OTCMKTS Market:
Cannabics Pharmaceuticals Inc Website:
CNBX Pharmaceuticals Inc (CNBX) is expected to report for Q1 2003
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma PR Newswire REHOVOT, Israel and BETHESDA, MD , Nov. 8, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader i...
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy PR Newswire REHOVOT, Israel and BETHESDA, MD. , Oct. 18, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of...